Yes, gonorrhea is curable. A single ceftriaxone injection given in a clinic clears almost every infection of the genitals, rectum, or throat CDC STI guidelines. Medicine kills the bacteria but can't undo damage already done, and drug-resistant strains are making treatment harder, so timing and follow-up matter.

Reported gonorrhea rate is falling (Cases per 100,000) 2021: 214; 2022: 194.4; 2023: 179.5 2021 214 2022 194.4 2023 179.5
Reported gonorrhea rate is falling. After a 2021 peak, the reported US gonorrhea rate dropped three years running. Source: CDC AtlasPlus, 2023.
Reported gonorrhea rate is falling (Cases per 100,000)
ItemCases per 100,000
2021214
2022194.4
2023179.5

So is gonorrhea curable — or not?

Gonorrhea is caused by the bacterium Neisseria gonorrhoeae, which can set up an infection in the urethra, cervix, rectum, or throat CDC. As of current guidance it remains curable with antibiotics, and no verified US clinical ceftriaxone treatment failures have been reported to date. A properly treated infection goes away.

The complication is resistance. Gonorrhea has steadily outrun nearly every drug thrown at it — sulfonamides, penicillin, tetracyclines, fluoroquinolones, and the oral cephalosporin cefixime have all lost reliability over time gonorrhea resistance review. Cephalosporins are now described as roughly the last fully recommended and effective class, and a ceftriaxone-resistant strain (FC428) emerged in Japan in 2015 and has since spread internationally. It's curable today while the medical world watches the door.

What 'cured' actually means here

A cure means the bacteria are eradicated, gone from every site they infected. It does not reverse harm the infection already caused. If gonorrhea has scarred a fallopian tube or inflamed the epididymis, antibiotics stop the infection but don't repair the tissue. The sooner you clear it, the less chance for lasting damage.

Cure is also site-specific. An infection of the throat behaves differently from one in the urethra, and 'cured' has to apply to every place the bacteria are living, so your clinician needs to know about oral and anal sex, not just vaginal.

The treatment that clears it

The recommended regimen is a single dose of ceftriaxone given as an intramuscular injection: 500 mg for people under 150 kg, and 1 g for people 150 kg or more MMWR 2020. One shot covers urogenital, rectal, and throat infection. If chlamydia hasn't been ruled out, your clinician adds a short course of doxycycline taken by mouth, because the two infections travel together. The full breakdown of doses and alternatives lives on our gonorrhea treatment page.

In 2020 the CDC moved from dual therapy to ceftriaxone alone. Previously the regimen paired ceftriaxone with azithromycin; azithromycin was dropped because resistance to it climbed fast — isolates with elevated azithromycin MICs rose from 0.6% in 2013 to 4.6% in 2018 — and over antimicrobial-stewardship and gut-microbiome concerns. At the same time the ceftriaxone dose was raised from 250 mg to 500 mg to keep it ahead of creeping resistance CID 2020. A single injection is now the lone first-line option, and oral pills are no longer trusted to do the job on their own.

There are backups. For a true cephalosporin allergy, the regimen is gentamicin by injection plus a single oral dose of azithromycin. If ceftriaxone simply isn't available, cefixime by mouth is an option, but it reliably treats only urogenital and rectal infection, not the throat, so a test-of-cure is required afterward. The deeper picture on resistance and why the injection is the standard is covered in our gonorrhea treatment explainer.

What the shot is actually like

Practically, treatment happens in the clinic. You get the ceftriaxone injection on-site, usually in the buttock or thigh, and walk out treated the same day. It's often free or low-cost at public health clinics. Take-home pills won't substitute; the oral-only era for gonorrhea is over. You'll also be told to abstain from sex for seven days after treatment so you don't pass it back to a partner or pick it up again.

Why fading symptoms isn't proof you're cured

Gonorrhea symptoms like discharge, burning, and throat irritation often ease within a few days of treatment, and sometimes they were never there. Feeling fine is not the same as being clear. Throat infections in particular are usually symptomless and can quietly persist for up to 16 weeks if not treated, so feeling okay tells you almost nothing about whether the bacteria are gone.

The throat is harder to cure than the genitals. Even fully susceptible pharyngeal infections failed ceftriaxone about 4.6% of the time in studies CDC drug-resistant gonorrhea. The pharynx also acts as a resistance breeding ground, where gonorrhea swaps resistance genes with harmless throat bacteria. So throat infection gets a follow-up test that genital infection doesn't.

Follow-up and retesting after treatment

There are two different follow-ups, and people confuse them. A test-of-cure confirms the bacteria are actually gone; a retest catches a brand-new infection later. Most genital and rectal infections don't need a test-of-cure if you got the recommended injection. The throat is the exception.

Follow-upWho needs itWhenWhy
Test-of-cureThroat infection, or anyone treated with cefixime7–14 days after treatment (culture preferred, or NAAT)Throat is harder to eradicate and cefixime doesn't reliably clear it
Retest for reinfectionEveryone treated for gonorrheaAbout 3 months after treatmentReinfection from an untreated partner is common

Most people who test positive again were reinfected rather than failed by treatment, so the three-month retest is standard, and partners matter. Notify and arrange treatment for anyone you've had sex with in the prior 60 days. For heterosexual partners who can't get seen in person, expedited partner therapy (a prescription of oral cefixime sent home for the partner) is an option where it's legally allowed. If you're unsure when to come back after a possible exposure, see when to test after exposure, and you can get tested for every site at once.

Getting every site swabbed

Testing is straightforward: a first-catch urine sample, plus a quick throat or rectal swab if you've had oral or anal sex. The single biggest mistake is leaving a site untested. Ask specifically for every exposed site or an infection gets missed and never cured. If you want to weigh at-home versus clinic options, you can compare testing providers.

What happens if gonorrhea goes untreated

Untreated, gonorrhea climbs from the first site of infection and causes real damage. In women it can lead to pelvic inflammatory disease (infection spreading into the uterus and tubes), fallopian-tube scarring, ectopic pregnancy (a pregnancy implanting outside the womb, which can be dangerous), infertility, and chronic pelvic pain. In men it can cause epididymitis (painful inflammation of the coiled tube behind the testicle, which can threaten fertility).

In either sex the bacteria can spill into the bloodstream and joints — disseminated gonococcal infection, or DGI — which causes fever, joint pain and skin lesions and can be life-threatening. DGI isn't treated like an ordinary case; it typically means hospitalization with ceftriaxone given every 24 hours. A pregnant person can also pass gonorrhea to a newborn at delivery, which is why it's screened in pregnancy. More on that in gonorrhea in pregnancy.

When to see a clinician

Get evaluated if you have discharge, burning with urination, throat or rectal symptoms, or you've learned a partner tested positive, even with no symptoms at all, since many infections are silent. Don't sit on a swollen, painful testicle; epididymitis needs prompt care, not a wait-and-see week. And after treatment, come back at three months to retest, because reinfection is common.

Prevention that holds up is unglamorous: condoms used correctly every time, regular testing of every exposed site, mutual monogamy or abstinence, and treating partners. DoxyPEP — a dose of doxycycline taken after sex — cuts chlamydia and syphilis sharply but works inconsistently against gonorrhea, and the CDC does not recommend it specifically for gonorrhea prevention, partly to avoid driving tetracycline resistance CDC DoxyPEP 2024.